サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1631243

C型肝炎ウイルス（HCV）検査の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2032年）

Hepatitis C virus (HCV) Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032

出版日
ページ情報
英文 190 Pages
納期
2～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
C型肝炎ウイルス（HCV）検査の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2032年）
出版日: 2025年01月08日
発行: Fairfield Market Research
ページ情報: 英文 190 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のC型肝炎ウイルス（HCV）検査の市場規模は、認知度の向上、診断技術の進歩、積極的なヘルスケアへの取り組みに後押しされ、一貫した成長を遂げています。2025年までに市場は8億9,400万米ドルに達すると予測され、2032年までに13億2,670万米ドルに増加すると予測され、CAGRは5.80%とみられています。

市場概要HCV検査は、世界の健康問題であるC型肝炎感染の特定と管理において重要な役割を果たしています。このプロセスでは、HCV RNAまたは抗体を検出し、早期介入と治療を可能にします。核酸や酵素免疫測定法を含む高度な診断技術により、正確で包括的な検査が可能となり、肝臓関連の合併症を減らすための公衆衛生戦略の要となっています。

HCV検査市場は、C型肝炎の有病率の上昇、診断技術の進歩、積極的な医療対策に牽引され、大きな成長が見込まれています。大手企業による戦略的な取り組みと早期発見への注力により、HCV感染症を管理するための効果的なソリューションが世界的に提供され、市場の牽引役となることが期待されます。継続的な進歩により、同市場は世界のヘルスケアにおいて重要な役割を果たすものと予測されています。

当レポートでは、世界のC型肝炎ウイルス（HCV）検査市場について調査し、市場の概要とともに、技法別、検査タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • ウクライナ・ロシア紛争の影響
  • 経済概要
  • PESTLE分析

第3章 2024年の価格分析

第4章 世界のC型肝炎ウイルス（HCV）検査市場の見通し、2019年～2032年

  • 世界のC型肝炎ウイルス（HCV）検査市場の見通し、技法別、金額（10億米ドル）、数量（件）、2019年～2032年
  • 世界のC型肝炎ウイルス（HCV）検査市場の見通し、検査タイプ別、価値（10億米ドル）、2019年～2032年
  • 世界のC型肝炎ウイルス（HCV）検査市場の見通し、エンドユーザー別、価値（10億米ドル）、2019年～2032年
  • 世界のC型肝炎ウイルス（HCV）検査市場の見通し、地域別、価値（10億米ドル）、数量（件）、2019年～2032年

第5章 北米のC型肝炎ウイルス（HCV）検査市場の見通し、2019年～2032年

第6章 欧州のC型肝炎ウイルス（HCV）検査市場の見通し、2019年～2032年

第7章 アジア太平洋のC型肝炎ウイルス（HCV）検査市場の見通し、2019年～2032年

第8章 ラテンアメリカのC型肝炎ウイルス（HCV）検査市場の見通し、2019年～2032年

第9章 中東・アフリカのC型肝炎ウイルス（HCV）検査市場の見通し、2019年～2032年

第10章 競合情勢

  • 企業市場シェア分析、2024年
  • 競合ダッシュボード
  • 企業プロファイル
    • OraSure Technologies, Inc.
    • Abbott Laboratories Inc.
    • Siemens Healthcare GmbH
    • Bio Rad Laboratories Inc.
    • Ortho Clinical Diagnostic Inc. (Johnson & Johnson)
    • Bayer AG
    • QIAGEN N.V.
    • Thermo Fisher Scientific Inc.
    • BioGenex
    • AccuQuick,
    • Roche Diagnostics (F. Hoffman-La Roche Ltd.)
    • STD Rapid Test Kits

第11章 付録

目次

The global Hepatitis C Virus (HCV) testing market is witnessing consistent growth, fueled by rising awareness, advancements in diagnostic technologies, and active healthcare initiatives. By 2025, the market is expected to reach 894 million, with projections indicating a rise to 1,326.7 million by 2032, reflecting a compound annual growth rate (CAGR) of 5.80%.

Market Overview HCV testing plays a vital role in identifying and managing Hepatitis C infections, a major global health concern. The process involves detecting HCV RNA or antibodies, enabling early intervention and treatment. Advanced diagnostic techniques, including nucleic acid and enzyme immunoassays, ensure accurate and comprehensive testing, making it a cornerstone in public health strategies to reduce liver-related complications.

The HCV testing market is poised for significant growth, driven by the rising prevalence of Hepatitis C, advancements in diagnostic technologies, and proactive healthcare measures. Strategic actions by major players and a focus on early detection are expected to drive the market forward, providing effective solutions for managing HCV infections globally. With continuous advancements, the market is positioned to play a critical role in global healthcare.

Key Market Drivers

  • 1. Increasing Hepatitis C Prevalence: The global rise in Hepatitis C infections has heightened the demand for accurate diagnostic methods. High-risk groups, such as individuals exposed to unsafe medical practices and intravenous drug users, underscore the importance of effective testing solutions.
  • 2. Technological Innovations: Breakthroughs in diagnostic technology, such as polymerase chain reaction (PCR) and advanced immunoassays, have improved the sensitivity and accuracy of HCV testing, encouraging wider adoption.
  • 3. Government and Awareness Campaigns: Efforts by governments and healthcare organizations to combat infectious diseases have boosted the uptake of HCV testing. Awareness programs highlighting early detection and treatment further drive market growth.

Opportunities for Growth The shift towards preventive healthcare and routine screenings creates lucrative opportunities for market participants. Increased investment in public health campaigns has made HCV testing a standard part of health evaluations, expanding its accessibility. Additionally, the adoption of point-of-care testing (POCT) technologies offers faster and more convenient diagnostic options in various healthcare settings.

Regional Insights

  • 1. Asia Pacific: This region holds the largest market share, driven by a large population base and significant prevalence of Hepatitis C infections. Enhanced healthcare infrastructure and supportive government initiatives further fuel market growth.
  • 2. Middle East & Africa: Expected to grow the fastest, this region faces unique infectious disease challenges. Investments in healthcare infrastructure and early diagnostic initiatives are fostering market expansion.
  • 3. North America and Europe: These regions exhibit steady growth due to advanced healthcare systems, widespread adoption of diagnostic technologies, and heightened public awareness.

Leading Market Players Key companies shaping the HCV testing market include:

  • Abbott Laboratories Inc.
  • Siemens Healthcare GmbH
  • Roche Diagnostics (F. Hoffmann-La Roche Ltd.)
  • Bio-Rad Laboratories Inc.
  • OraSure Technologies, Inc.
  • Bayer AG
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.
  • Ortho Clinical Diagnostics Inc. (Johnson & Johnson)

These industry leaders employ strategies such as technological advancements, strategic partnerships, and awareness campaigns to strengthen their market positions. For instance, Abbott Laboratories' ARCHITECT anti-HCV immunoassay and Roche Diagnostics' PCR-based assays highlight their dedication to providing precise and reliable diagnostic solutions.

Market Segmentation

1. By Technique:

    Immunoassays-based Hepatitis C Virus Testing Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing Other Testing Techniques

2. By Test Type:

    HCV Antibody Testing HCV Viral Load Testing HCV Genotyping Testing

3. By End User:

    Hospitals Diagnostic Centers Blood Donation Centers

4. By Region:

    North America Europe Asia Pacific Latin America Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Hepatitis C virus (HCV) Testing Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume (Units), 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Price Analysis, 2024

  • 3.1. Global Average Price Analysis, by Technique, US$ Per Unit, 2019 - 2023
  • 3.2. Prominent Factor Affecting Hepatitis C virus (HCV) Testing Prices
  • 3.3. Global Average Price Analysis, by Region, US$ Per Unit

4. Global Hepatitis C virus (HCV) Testing Market Outlook, 2019 - 2032

  • 4.1. Global Hepatitis C virus (HCV) Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 4.1.1. Key Highlights
      • 4.1.1.1. Immunoassays-based Hepatitis C Virus Testing
      • 4.1.1.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
      • 4.1.1.3. Other Hepatitis C Virus Testing Techniques
  • 4.2. Global Hepatitis C virus (HCV) Testing Market Outlook, by Test Type, Value (US$ Bn, 2019 - 2032
    • 4.2.1. Key Highlights
      • 4.2.1.1. HCV Antibody Testing
      • 4.2.1.2. HCV Viral Load Testing
      • 4.2.1.3. HCV Genotyping Testing
  • 4.3. Global Hepatitis C virus (HCV) Testing Market Outlook, by End-user, Value (US$ Bn, 2019 - 2032
    • 4.3.1. Key Highlights
      • 4.3.1.1. Hospitals
      • 4.3.1.2. Diagnostic Centers
      • 4.3.1.3. Blood Donation Centers
  • 4.4. Global Hepatitis C virus (HCV) Testing Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 4.4.1. Key Highlights
      • 4.4.1.1. North America
      • 4.4.1.2. Europe
      • 4.4.1.3. Asia Pacific
      • 4.4.1.4. Latin America
      • 4.4.1.5. Middle East & Africa

5. North America Hepatitis C virus (HCV) Testing Market Outlook, 2019 - 2032

  • 5.1. North America Hepatitis C virus (HCV) Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Immunoassays-based Hepatitis C Virus Testing
      • 5.1.1.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
      • 5.1.1.3. Other Hepatitis C Virus Testing Techniques
  • 5.2. North America Hepatitis C virus (HCV) Testing Market Outlook, by Test Type, Value (US$ Bn, 2019 - 2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. HCV Antibody Testing
      • 5.2.1.2. HCV Viral Load Testing
      • 5.2.1.3. HCV Genotyping Testing
  • 5.3. North America Hepatitis C virus (HCV) Testing Market Outlook, by End-user, Value (US$ Bn, 2019 - 2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospitals
      • 5.3.1.2. Diagnostic Centers
      • 5.3.1.3. Blood Donation Centers
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis
  • 5.4. North America Hepatitis C virus (HCV) Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.4.1. Key Highlights
      • 5.4.1.1. U.S. Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.4.1.2. U.S. Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.3. U.S. Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 5.4.1.4. Canada Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.4.1.5. Canada Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.6. Canada Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Europe Hepatitis C virus (HCV) Testing Market Outlook, 2019 - 2032

  • 6.1. Europe Hepatitis C virus (HCV) Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Immunoassays-based Hepatitis C Virus Testing
      • 6.1.1.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
      • 6.1.1.3. Other Hepatitis C Virus Testing Techniques
  • 6.2. Europe Hepatitis C virus (HCV) Testing Market Outlook, by Test Type, Value (US$ Bn, 2019 - 2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. HCV Antibody Testing
      • 6.2.1.2. HCV Viral Load Testing
      • 6.2.1.3. HCV Genotyping Testing
  • 6.3. Europe Hepatitis C virus (HCV) Testing Market Outlook, by End-user, Value (US$ Bn, 2019 - 2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospitals
      • 6.3.1.2. Diagnostic Centers
      • 6.3.1.3. Blood Donation Centers
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. Europe Hepatitis C virus (HCV) Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.4.1. Key Highlights
      • 6.4.1.1. Germany Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.2. Germany Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.3. Germany Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 6.4.1.4. U.K. Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.5. U.K. Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.6. U.K. Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 6.4.1.7. France Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.8. France Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.9. France Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 6.4.1.10. Italy Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.11. Italy Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.12. Italy Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 6.4.1.13. Turkey Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.14. Turkey Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.15. Turkey Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 6.4.1.16. Russia Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.17. Russia Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.18. Russia Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 6.4.1.19. Rest of Europe Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.20. Rest of Europe Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.21. Rest of Europe Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Asia Pacific Hepatitis C virus (HCV) Testing Market Outlook, 2019 - 2032

  • 7.1. Asia Pacific Hepatitis C virus (HCV) Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Immunoassays-based Hepatitis C Virus Testing
      • 7.1.1.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
      • 7.1.1.3. Other Hepatitis C Virus Testing Techniques
  • 7.2. Asia Pacific Hepatitis C virus (HCV) Testing Market Outlook, by Test Type, Value (US$ Bn, 2019 - 2032
    • 7.2.1. Key Highlights
      • 7.2.1.1. HCV Antibody Testing
      • 7.2.1.2. HCV Viral Load Testing
      • 7.2.1.3. HCV Genotyping Testing
  • 7.3. Asia Pacific Hepatitis C virus (HCV) Testing Market Outlook, by End-user, Value (US$ Bn, 2019 - 2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospitals
      • 7.3.1.2. Diagnostic Centers
      • 7.3.1.3. Blood Donation Centers
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Asia Pacific Hepatitis C virus (HCV) Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.4.1. Key Highlights
      • 7.4.1.1. China Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.4.1.2. China Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.3. China Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 7.4.1.4. Japan Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.4.1.5. Japan Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.6. Japan Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 7.4.1.7. South Korea Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.4.1.8. South Korea Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.9. South Korea Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 7.4.1.10. India Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.4.1.11. India Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.12. India Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 7.4.1.13. Southeast Asia Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.4.1.14. Southeast Asia Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.15. Southeast Asia Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 7.4.1.16. Rest of Asia Pacific Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.4.1.17. Rest of Asia Pacific Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.18. Rest of Asia Pacific Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Latin America Hepatitis C virus (HCV) Testing Market Outlook, 2019 - 2032

  • 8.1. Latin America Hepatitis C virus (HCV) Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Immunoassays-based Hepatitis C Virus Testing
      • 8.1.1.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
      • 8.1.1.3. Other Hepatitis C Virus Testing Techniques
  • 8.2. Latin America Hepatitis C virus (HCV) Testing Market Outlook, by Test Type, Value (US$ Bn, 2019 - 2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. HCV Antibody Testing
      • 8.2.1.2. HCV Viral Load Testing
      • 8.2.1.3. HCV Genotyping Testing
  • 8.3. Latin America Hepatitis C virus (HCV) Testing Market Outlook, by End-user, Value (US$ Bn, 2019 - 2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospitals
      • 8.3.1.2. Diagnostic Centers
      • 8.3.1.3. Blood Donation Centers
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Latin America Hepatitis C virus (HCV) Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.4.1. Key Highlights
      • 8.4.1.1. Brazil Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.4.1.2. Brazil Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.3. Brazil Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 8.4.1.4. Mexico Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.4.1.5. Mexico Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.6. Mexico Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 8.4.1.7. Argentina Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.4.1.8. Argentina Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.9. Argentina Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 8.4.1.10. Rest of Latin America Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.4.1.11. Rest of Latin America Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.12. Rest of Latin Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Middle East & Africa Hepatitis C virus (HCV) Testing Market Outlook, 2019 - 2032

  • 9.1. Middle East & Africa Hepatitis C virus (HCV) Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.1.1. Key Highlights
      • 9.1.1.1. Immunoassays-based Hepatitis C Virus Testing
      • 9.1.1.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
      • 9.1.1.3. Other Hepatitis C Virus Testing Techniques
  • 9.2. Middle East & Africa Hepatitis C virus (HCV) Testing Market Outlook, by Test Type, Value (US$ Bn, 2019 - 2032
    • 9.2.1. Key Highlights
      • 9.2.1.1. HCV Antibody Testing
      • 9.2.1.2. HCV Viral Load Testing
      • 9.2.1.3. HCV Genotyping Testing
  • 9.3. Middle East & Africa Hepatitis C virus (HCV) Testing Market Outlook, by End-user, Value (US$ Bn, 2019 - 2032
    • 9.3.1. Key Highlights
      • 9.3.1.1. Hospitals
      • 9.3.1.2. Diagnostic Centers
      • 9.3.1.3. Blood Donation Centers
    • 9.3.2. BPS Analysis/Market Attractiveness Analysis
  • 9.4. Middle East & Africa Hepatitis C virus (HCV) Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.4.1. Key Highlights
      • 9.4.1.1. GCC Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.4.1.2. GCC Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 9.4.1.3. GCC Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 9.4.1.4. South Africa Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.4.1.5. South Africa Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 9.4.1.6. South Africa Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 9.4.1.7. Egypt Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.4.1.8. Egypt Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 9.4.1.9. Egypt Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 9.4.1.10. Nigeria Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.4.1.11. Nigeria Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 9.4.1.12. Nigeria Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
      • 9.4.1.13. Rest of Middle East & Africa Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.4.1.14. Rest of Middle East & Africa Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
      • 9.4.1.15. Rest of Middle East & Africa Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Competitive Landscape

  • 10.1. Company Market Share Analysis, 2024
  • 10.2. Competitive Dashboard
  • 10.3. Company Profiles
    • 10.3.1. OraSure Technologies, Inc.
      • 10.3.1.1. Company Overview
      • 10.3.1.2. Technique Portfolio
      • 10.3.1.3. Financial Overview
      • 10.3.1.4. Business Strategies and Development
    • 10.3.2. Abbott Laboratories Inc.
      • 10.3.2.1. Company Overview
      • 10.3.2.2. Technique Portfolio
      • 10.3.2.3. Financial Overview
      • 10.3.2.4. Business Strategies and Development
    • 10.3.3. Siemens Healthcare GmbH
      • 10.3.3.1. Company Overview
      • 10.3.3.2. Technique Portfolio
      • 10.3.3.3. Financial Overview
      • 10.3.3.4. Business Strategies and Development
    • 10.3.4. Bio Rad Laboratories Inc.
      • 10.3.4.1. Company Overview
      • 10.3.4.2. Technique Portfolio
      • 10.3.4.3. Financial Overview
      • 10.3.4.4. Business Strategies and Development
    • 10.3.5. Ortho Clinical Diagnostic Inc. (Johnson & Johnson)
      • 10.3.5.1. Company Overview
      • 10.3.5.2. Technique Portfolio
      • 10.3.5.3. Financial Overview
      • 10.3.5.4. Business Strategies and Development
    • 10.3.6. Bayer AG
      • 10.3.6.1. Company Overview
      • 10.3.6.2. Technique Portfolio
      • 10.3.6.3. Financial Overview
      • 10.3.6.4. Business Strategies and Development
    • 10.3.7. QIAGEN N.V.
      • 10.3.7.1. Company Overview
      • 10.3.7.2. Technique Portfolio
      • 10.3.7.3. Financial Overview
      • 10.3.7.4. Business Strategies and Development
    • 10.3.8. Thermo Fisher Scientific Inc.
      • 10.3.8.1. Company Overview
      • 10.3.8.2. Technique Portfolio
      • 10.3.8.3. Financial Overview
      • 10.3.8.4. Business Strategies and Development
    • 10.3.9. BioGenex
      • 10.3.9.1. Company Overview
      • 10.3.9.2. Technique Portfolio
      • 10.3.9.3. Financial Overview
      • 10.3.9.4. Business Strategies and Development
    • 10.3.10. AccuQuick,
      • 10.3.10.1. Company Overview
      • 10.3.10.2. Technique Portfolio
      • 10.3.10.3. Financial Overview
      • 10.3.10.4. Business Strategies and Development
    • 10.3.11. Roche Diagnostics (F. Hoffman-La Roche Ltd.)
      • 10.3.11.1. Company Overview
      • 10.3.11.2. Technique Portfolio
      • 10.3.11.3. Financial Overview
      • 10.3.11.4. Business Strategies and Development
    • 10.3.12. STD Rapid Test Kits
      • 10.3.12.1. Company Overview
      • 10.3.12.2. Technique Portfolio
      • 10.3.12.3. Financial Overview
      • 10.3.12.4. Business Strategies and Development

11. Appendix

  • 11.1. Research Methodology
  • 11.2. Report Assumptions
  • 11.3. Acronyms and Abbreviations